[1] V. Dolce, P. Scarcia, D. Iacopetta, F. Palmieri. A fourth ADP/ATP carrier isoform in man: Identification, bacterial expression, functional characterization and tissue distribution. FEBS Lett., 579, 633-637(2005).
[2] G. Stepien, A. Torroni, A. B. Chung, J. A. Hodge, D. C. Wallace. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J. Biol. Chem., 267, 14592-14597(1992).
[3] J. W. Ellison, E. C. Salido, L. J. Shapiro. Genetic mapping of the adenine nucleotide translocase-2 gene (Ant2) to the mouse proximal X chromosome. Genomics, 36, 369-371(1996).
[4] B. H. Graham, K. G. Waymire, B. Cottrell, I. A. Trounce, G. R. MacGregor, D. C. Wallace. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat. Genet., 16, 226-234(1997).
[5] S. E. Levy, Y. S. Chen, B. H. Graham, D. C. Wallace. Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. Gene, 254, 57-66(2000).
[6] M. D. Brown, D. C. Wallace. Molecular basis of mitochondrial DNA disease. J. Bioenerg. Biomembr., 26, 273-289(1994).
[7] R. M. Morrow, M. Picard, O. Derbeneva, J. Leipzig, M. J. McManus, G. Gouspillou, S. Barbat-Artigas, C. Dos Santos, R. T. Hepple, D. G. Murdock, D. C. Wallace. Mitochondrial energy deficiency leads to hyperproliferation of skeletal muscle mitochondria and enhanced insulin sensitivity. Proc. Natl. Acad. Sci. USA, 114, 2705-2710(2017).
[8] P. M. Schaefer, J. Huang, A. Butic, C. Perry, T. Yardeni, W. Tan, R. Morrow, J. A. Baur, D. C. Wallace. Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice. Mol. Metabol., 64, 101560(2022).
[9] K. P. Quinn, G. V. Sridharan, R. S. Hayden, D. L. Kaplan, K. Lee, I. Georgakoudi. Quantitative metabolic imaging using endogenous fluorescence to detect stem cell differentiation. Sci. Rep., 3, 1-10(2013).
[10] A. Varone, J. Xylas, K. P. Quinn, D. Pouli, G. Sridharan, M. E. McLaughlin-Drubin, C. Alonzo, K. Lee, K. Munger, I. Georgakoudi. Endogenous two-photon fluorescence imaging elucidates metabolic changes related to enhanced glycolysis and glutamine consumption in precancerous epithelial tissues. Cancer Res., 74, 3067-3075(2014).
[11] B. Chance, B. Schoener, R. Oshino, F. Itshak, Y. Nakase. Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals. J. Biol. Chem., 254, 4764-4771(1979).
[12] B. Quistorff, J. C. Haselgrove, B. Chance. High spatial resolution readout of 3-D metabolic organ structure: An automated, low-temperature redox ratio-scanning instrument. Anal. Biochem., 148, 389-400(1985).
[13] Y. Gu, Z. Qian, J. Chen, D. Blessington, N. Ramanujam, B. Chance. High-resolution three-dimensional scanning optical image system for intrinsic and extrinsic contrast agents in tissue. Rev. Sci. Instrum., 73, 172-178(2002).
[14] C. H. Barlow, W. R., Harden, A. H. Harken, M. B. Simson, J. C. Haselgrove, B. Chance, M. O’Connor, G. Austin. Fluorescence mapping of mitochrondrial redox changes in heart and brain. Crit. Care Med., 7, 402-406(1979).
[15] H. N. Xu, L. Z. Li. Quantitative redox imaging biomarkers for studying tissue metabolic state and its heterogeneity. J. Innov. Opt. Health Sci., 7, 1430002(2014).
[16] H. N. Xu, S. Nioka, J. D. Glickson, B. Chance, L. Z. Li. Quantitative mitochondrial redox imaging of breast cancer metastatic potential. J. Biomed. Opt., 15, 036010(2010).
[17] H. N. Xu, M. Feng, L. Moon, N. Dolloff, W. El-Deiry, L. Z. Li. Redox imaging of the p53-dependent mitochondrial redox state in colon cancer ex vivo. J. Innov. Opt. Health Sci., 06, 1350016(2013).
[18] H. N. Xu, S. Nioka, L. Z. Li. Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomarker Res., 1, 6(2013).
